ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

YourUpdateTV Speaks with Mathew Knowles and Ruth Tennen from 23andMe to Discuss Genetic Risk Factors for Cancer

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- February is Cancer Prevention Month, and the perfect opportunity to highlight the importance of genetic testing in understanding cancer risk factors. Recently, Global Ambassador for 23andMe, Mathew Knowles, and Senior Product Scientist, Ruth Tennen, participated in a nationwide satellite media tour to discuss how genetic insights can empower individuals to make informed decisions about their health.

Up to ten percent of all cancers are due to inherited genetic variants passed down through families. BRCA1 and 2 are regular genes that everybody has. Their normal job is to repair broken DNA, which helps prevent cancer. But about 1 out of every 200 people inherit a genetic variant, or mutation, that stops one of these genes from working properly. And this results in a significantly higher risk of developing certain cancers, including breast cancer in both women and men, along with ovarian, prostate, and pancreatic cancer.

The good news is that if you know you have a BRCA variant, you can take steps to reduce your cancer risk, including enhanced screening, medications, and surgeries. But unfortunately, about 80% of people with a BRCA variant don't know they have one, because they've never had genetic testing. Many do not have a family history of cancer that would qualify them for traditional genetic testing through a healthcare professional. Layered onto that are disparities in access to BRCA1/2 genetic testing in some communities in the U.S., including the Black, Hispanic/Latino, and Asian communities.

Mathew Knowles, known for his successful career in the music industry and as the father of Beyoncé and Solange, was diagnosed with breast cancer in 2019. His diagnosis led him to explore his genetic makeup, and he discovered he carried a BRCA2 variant—an inherited genetic variant that significantly increases the risk of developing certain cancers, including breast cancer. Since his diagnosis, Knowles has been an outspoken advocate for genetic testing, particularly within the African American community, which is often underrepresented in discussions of genetic risk and cancer prevention.

For more information, visit 23andMe.com

* YourUpdateTV is a property of D S Simon Media. The video included and release was part of a media tour that was produced by D S Simon Media on behalf of 23andMe

Media Contact:
Michael O’Donnell
D S Simon Media
212-736-2727
modonnell@dssimon.com

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/04654b5e-f7cb-4890-b047-57ec7f23183d


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.53
+0.42 (0.18%)
AAPL  278.78
-1.92 (-0.68%)
AMD  217.97
+1.99 (0.92%)
BAC  53.95
+0.07 (0.13%)
GOOG  322.09
+3.70 (1.16%)
META  673.42
+11.89 (1.80%)
MSFT  483.16
+2.32 (0.48%)
NVDA  182.41
-0.97 (-0.53%)
ORCL  217.58
+3.25 (1.52%)
TSLA  455.00
+0.47 (0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.